Teleflex Incorporated (NYSE:TFX) Shares Acquired by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd increased its position in shares of Teleflex Incorporated (NYSE:TFX) by 2.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,991 shares of the medical technology company’s stock after acquiring an additional 118 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Teleflex were worth $888,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Simplify Asset Management Inc. acquired a new stake in shares of Teleflex during the third quarter worth about $4,800,000. JPMorgan Chase & Co. lifted its holdings in Teleflex by 14.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after buying an additional 19,466 shares in the last quarter. LGT Capital Partners LTD. boosted its position in Teleflex by 4.2% in the 3rd quarter. LGT Capital Partners LTD. now owns 231,685 shares of the medical technology company’s stock valued at $57,300,000 after buying an additional 9,411 shares during the period. Boston Trust Walden Corp grew its stake in shares of Teleflex by 3.9% in the fourth quarter. Boston Trust Walden Corp now owns 294,614 shares of the medical technology company’s stock worth $52,435,000 after acquiring an additional 11,052 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC increased its position in shares of Teleflex by 41.5% during the third quarter. Allspring Global Investments Holdings LLC now owns 24,301 shares of the medical technology company’s stock worth $6,010,000 after acquiring an additional 7,132 shares during the period. 95.62% of the stock is currently owned by hedge funds and other institutional investors.

Teleflex Price Performance

TFX stock opened at $171.37 on Wednesday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $7.96 billion, a P/E ratio of 34.07, a PEG ratio of 1.72 and a beta of 1.16. The business has a 50 day simple moving average of $179.58 and a 200-day simple moving average of $210.72. Teleflex Incorporated has a twelve month low of $169.99 and a twelve month high of $256.85.

Analyst Ratings Changes

Several research analysts recently commented on the company. Mizuho lowered their target price on Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Truist Financial lowered their price target on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a report on Wednesday, December 18th. StockNews.com upgraded Teleflex from a “hold” rating to a “buy” rating in a research note on Thursday, November 28th. Finally, Royal Bank of Canada lowered their target price on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a report on Friday, November 1st. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.